Article Details

Soricimed to Investigate the Potential Benefit of SOR-C13 in the Treatment of COVID-19

Retrieved on: 2020-12-17 14:02:32

Tags for this article:

Click the tags to see associated articles and topics

Soricimed to Investigate the Potential Benefit of SOR-C13 in the Treatment of COVID-19. View article details on hiswai:

Excerpt

About Soricimed <b>Biopharma</b> Inc. Soricimed is a privately-held, clinical stage company focused primarily on the development of targeted, first-in-class ...

Article found on: www.newswire.ca

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up